These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27414740)

  • 21. Paliperidone Injection-Associated Delayed-Onset Rash.
    Sundling K; Held J; Narang P; Lippmann S
    Prim Care Companion CNS Disord; 2019 Jan; 21(1):. PubMed ID: 30817863
    [No Abstract]   [Full Text] [Related]  

  • 22. Risperidone is not only a prodrug: psychosis induced by medication switch from risperidone to paliperidone - a case report.
    Dagenais-Beaulé V
    Eur J Hosp Pharm; 2023 Jul; 30(4):e20. PubMed ID: 34785566
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Naguy A; Al-Khadhari S
    Psychopharmacol Bull; 2024 Jul; 54(3):100-102. PubMed ID: 38993660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute agranulocytosis when switching from risperidone to paliperidone.
    Wakuda T; Suzuki A; Hasegawa M; Ichikawa D; Yamasue H
    Aust N Z J Psychiatry; 2019 Jun; 53(6):586-587. PubMed ID: 30636434
    [No Abstract]   [Full Text] [Related]  

  • 25. Paliperidone Palmitate-Induced Delirium in an Adolescent with Schizophrenia: Case report.
    Mirza H; Harding D; Al-Balushi N
    Sultan Qaboos Univ Med J; 2018 May; 18(2):e208-e210. PubMed ID: 30210852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost effectiveness of paliperidone palmitate versus oral antipsychotics in patients with schizophrenia and a history of criminal justice involvement.
    Muser E; Kozma CM; Benson CJ; Mao L; Starr HL; Alphs L; Fastenau J
    J Med Econ; 2015; 18(8):637-45. PubMed ID: 25851616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lower risk for body weight gain and better control of appetite after switching risperidone to paliperidone in a schizoaffective patient.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E36-7. PubMed ID: 24763786
    [No Abstract]   [Full Text] [Related]  

  • 28. Drugs for psychotic disorders.
    Med Lett Drugs Ther; 2016 Dec; 58(1510):160-164. PubMed ID: 27960194
    [No Abstract]   [Full Text] [Related]  

  • 29. A patient with multiple episodes of rhabdomyolysis induced by different neuroleptics.
    Aggarwal R; Guanci N; Marambage K; Caplan JP
    Psychosomatics; 2014; 55(4):404-408. PubMed ID: 24016383
    [No Abstract]   [Full Text] [Related]  

  • 30. Improvement in psychotic symptoms and social functioning after augmentation of paliperidone with clozapine in a patient with schizoaffective disorder.
    Hou YC
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):E26. PubMed ID: 24515699
    [No Abstract]   [Full Text] [Related]  

  • 31. The preclinical discovery and development of paliperidone for the treatment of schizophrenia.
    Wesołowska A; Jastrzębska-Więsek M; Cios A; Partyka A
    Expert Opin Drug Discov; 2020 Mar; 15(3):279-292. PubMed ID: 31661992
    [No Abstract]   [Full Text] [Related]  

  • 32. Paliperidone palmitate use in pregnancy in a woman with schizophrenia.
    Özdemir AK; Pak ŞC; Canan F; Geçici Ö; Kuloğlu M; Gücer MK
    Arch Womens Ment Health; 2015 Oct; 18(5):739-40. PubMed ID: 25599999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder.
    Bossie CA; Turkoz I; Alphs L; Mahalchick L; Fu DJ
    J Nerv Ment Dis; 2017 Apr; 205(4):324-328. PubMed ID: 28005578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Satisfaction of immediate or delayed switch to paliperidone palmitate in patients unsatisfied with current oral atypical antipsychotics.
    Kwon JS; Kim SN; Han J; Lee SI; Chang JS; Choi JS; Lee HJ; Cho SJ; Jun TY; Lee SH; Han C; Lee KU; Lee KK; Lee E
    Int Clin Psychopharmacol; 2015 Nov; 30(6):320-8. PubMed ID: 26196188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxic Epidermal Necrolysis Related to Paliperidone Palmitate: First Case Report.
    Struye A; Depuydt C; Abdel Sater E; Dubois V
    J Clin Psychopharmacol; 2016 Jun; 36(3):279-82. PubMed ID: 26928057
    [No Abstract]   [Full Text] [Related]  

  • 36. Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence.
    Greenberg WM; Citrome L
    Neurol Ther; 2015 Dec; 4(2):81-91. PubMed ID: 26662360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angioedema Associated With Long-Acting Injectable Paliperidone Palmitate: A Case Report.
    Papadopoulou A; Gkikas K; Efstathiou V; Gkikas I; Kokoris S; Lagari V; Papageorgiou C; Douzenis A; Siafakas N; Rizos EN
    J Clin Psychopharmacol; 2017 Dec; 37(6):730-732. PubMed ID: 29028688
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of psychotic schizophrenia spectrum disorders in adolescents].
    Popov YV; Yakovleva YA; Pisevich MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(10):47-50. PubMed ID: 26525621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late-onset Neuroleptic Malignant Syndrome Associated With Paliperidone Long-acting Injection and Lithium: A Case Report.
    Netcheva Z; Shin K
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):333-335. PubMed ID: 33605644
    [No Abstract]   [Full Text] [Related]  

  • 40. Paliperidone and pregnancy-an evaluation of the German Embryotox database.
    Onken M; Mick I; Schaefer C
    Arch Womens Ment Health; 2018 Dec; 21(6):657-662. PubMed ID: 29569043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.